The three syndromes and six Chinese patent medicine study during the recovery phase of COVID-19

The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), first broke out in Wuhan, China, in 2019. SARS-CoV-2 develops many types of mutations (such as B.1.1.7), making diagnosis and treatment challenging. Although we now have a preliminary und...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Xuedong, Duan, Liyun, Zhang, Yue Hong, Jin, De, Zhao, Shenghui, Zhou, Rong Rong, Duan, Yingying, Lian, Fengmei, Tong, Xiaolin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182732/
https://www.ncbi.nlm.nih.gov/pubmed/34099015
http://dx.doi.org/10.1186/s13020-021-00454-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182732/
https://www.ncbi.nlm.nih.gov/pubmed/34099015
http://dx.doi.org/10.1186/s13020-021-00454-x

Ejemplares similares